The FDA panel, although concerned about Lemtrada and its possible risks, understands the need for MS medication, and agrees that MS patients can make the decision on the risk/reward of this new drug! Yay! Someone is listening.
http://www.medpagetoday.com/Neurolog...14&utm_content
http://www.medpagetoday.com/Neurolog...14&utm_content
Comment